| Dr Kari Wilson, PHARMD | |
|
4910 N Us Highway 89, Safeway Pharmacy Dept, Flagstaff, AZ 86004-2846 | |
| (928) 526-5686 | |
| (928) 526-4710 |
| Full Name | Dr Kari Wilson |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 4910 N Us Highway 89, Flagstaff, Arizona |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114227105 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | SO10498 (Arizona) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kari Wilson, PHARMD 4910 N Us Highway 89, Safeway Pharmacy Dept, Flagstaff, AZ 86004-2846 Ph: (928) 526-5686 | Dr Kari Wilson, PHARMD 4910 N Us Highway 89, Safeway Pharmacy Dept, Flagstaff, AZ 86004-2846 Ph: (928) 526-5686 |
News Archive
A research conducted by Juan Méndez, Head of the DNA Replication Group of the Spanish National Cancer Research Centre (CNIO), sheds light on the molecular mechanisms of ageing of the stem cells responsible for regenerating blood cells and opens up a new avenue for reducing their progressive functional decline with age.
The testing of DNA from a statewide blood screening program for newborns in Wisconsin was able to identify infants with T-cell lymphopenia, a blood disorder that affects the child's immune system, a disease in which early identification is important, according to a study in the December 9 issue of JAMA.
Fatal bleeding is rare with extended dual antiplatelet therapy, according to a secondary analysis of the DAPT Study presented for the first time today at ESC Congress. Bleeding-related mortality accounted for a minority of deaths in patients treated with dual antiplatelet therapy beyond one year.
VIA Pharmaceuticals, Inc., a biotechnology company focused on the development of compounds for the treatment of cardiovascular and metabolic diseases, today announced that Dr. Rebecca Taub, Senior Vice President Research & Development will present "Liver Directed Beta Agonist for Targeting Cardiometabolic Disease", and will discuss the Company's cardio-metabolic product portfolio, including VIA's inhibitor of 5 Lipoxygenase, its THR Beta Agonist, and its DGAT1 development programs, at the Cambridge Healthtech Institute Seventh International Discovery on Target 2009 program, on November 3, 2009 in Boston, MA.
Perrigo Company today announced that it has launched, through a distribution and supply agreement, methazolamide tablets, the generic equivalent to Neptazane tablets. This product is a component of the contingent rights Perrigo received in connection with its acquisition of a portfolio of ophthalmic products from Fera Pharmaceuticals, LLC and its affiliates in June of last year.
› Verified 9 days ago
Dr. Whitney Farnsworth Morejon, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1201 S Plaza Way, Flagstaff, AZ 86001 Phone: 928-556-9170 | |
Teresa Jesus Aleman, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2920 N 4th St, Flagstaff, AZ 86004 Phone: 928-522-9403 | |
Dr. Cody Ray Plaisted, PHARM. D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3480 E Route 66, Flagstaff, AZ 86004 Phone: 307-399-5957 | |
Nathaniel Green, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1025 S Milton Rd, Flagstaff, AZ 86001 Phone: 928-779-9588 | |
Melissa C Kelly, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2610 E Route 66, Flagstaff, AZ 86004 Phone: 928-773-1155 | |
Christine Long, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2601 E Huntington Dr, Flagstaff, AZ 86004 Phone: 928-774-3409 |